About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

French President Macron: The situation in Iran is unstable and the risks are escalating.

2026-03-10

French President Macron: The situation in Iran is unstable and the risks are escalating.

Other News
2026-03-10

Individual Stock News 1. CATL (03750.HK) announced its 2025 results: net profit attributable to shareholders of approximately RMB 72.201 billion, a year-on-year increase of 42.28%, with a cash dividend of RMB 69.57 per 10 shares. 2. Huicai Holdings

Individual Stock News 1. CATL (03750.HK) announced its 2025 results: net profit attributable to shareholders of approximately RMB 72.201 billion, a year-on-year increase of 42.28%, with a cash dividend of RMB 69.57 per 10 shares. 2. Huicai Holdings (01180.HK) issued a profit warning: 2025 profit is expected to decrease by 63.5% year-on-year. 3. Tanwan (09890.HK) issued a profit alert: 2025 net profit is expected to increase significantly to no less than RMB 1.5 billion. 4. China Nuclear Energy Technology (00611.HK) issued a profit alert: 2025 net profit is expected to increase by approximately 40% to 50% year-on-year. 5. Huaxian Optoelectronics (00334.HK): A subsidiary plans to acquire equipment and machinery for the production of LCD modules for RMB 33.268 million. 6. China Jinmao (00817.HK): Contracted sales amounted to RMB 12.93 billion in the first two months, a year-on-year increase of 16.37%. 7. Ziyuanyuan (08223.HK): Plans to issue 86 million subscription shares at a discount of approximately 9.09%, raising net proceeds of approximately HKD 42.5 million. 8. Huaxian Optoelectronics (00334.HK) issued a profit warning: It expects profit attributable to owners of the parent company to increase by no less than 80% year-on-year in 2025. 9. Fosun Pharma (02696.HK): The clinical trial application for HLX3901 injection in patients with advanced/metastatic solid tumors has been approved by the National Medical Products Administration. 10. Junshi Biosciences (01877.HK): The marketing application for toripalimab injection (subcutaneous injection) has been accepted.
2026-03-10

Eurogroup President Pierakakis: We are witnessing upward pressure on energy prices.

Eurogroup President Pierakakis: We are witnessing upward pressure on energy prices.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.